Effect of hepatitis B virus infection on right and left ventricular functions

Medical Science Monitor

Volumn 18, Issue 9, 2012, Pages

  Demir, Mehmet ^a   Demir, Canan ^b  

^a BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Bursa Sevket Yilmaz Education and Research Hospital   (Turkey)

Author keywords

Cardiomyopathy; Hepatitis B virus; Myocarditis; Pulmonary artery hypertension

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FLOW RATE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LUNG ARTERY PRESSURE; MALE; MYOCARDIAL SYSTOLIC VELOCITY; MYOCARDITIS; PARAMETERS; PULMONARY HYPERTENSION; RIGHT HEART VENTRICLE SYSTOLIC DYSFUNCTION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID ANNULAR PLANE EXCURSION;

EID: 84866076940     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883356     Document Type: Article

References (26)

1. Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat, 2004; 11: 7-107
2. Kwon SY, Lee CH: The Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol, 2011; 17: 87-95
3. Fattovich G: Natural history and prognosis of hepatitis B. Semin Liver Dis, 2003; 23: 47-58
4. Ganem D, Prince AM: Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med, 2004; 350: 1118-29
5. Kadiroǧlu AK, Göral V, Şit D et al: The evaluation of the prevalence of extrahepatic findings in chronic hepatitis-C virus infection. Türkiye Klinikleri J Med Sci, 2005; 25: 621-26
6. Matsumori A. Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus. Intern Med, 2001; 40: 182-84
7. Rong Q, Huang J, Su E et al: Infection of hepatitis B virus in extrahepatic endothelial tissues mediated by endothelial progenitor cells. Virol J, 2007; 4: 36
8. Franceschi SS, Lise M, Trépo C et al: Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev, 2011; 20(1): 208-14
9. Matsumori A, Ohashi N, Hasegawa K et al: Hepatitis C virüs infection and heart diseases: a multicenter study in Japan. Jpn Circ J, 1998; 62: 389-91
10. Matsumori A: Hepatitis C virus infection and cardiomyopathies. Circ Res, 2005; 96: 144-47
11. Matsumori A, Ohashi N, Sasayama S: Hepatitis C virus infection and hypertrophic cardiomyopathy. Ann Intern Med, 1998; 129: 749-50
12. Matsumori A, Matoba Y, Sasayama S: Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation, 1995; 92: 2519-25
13. Kühl U, Pauschinger M, Seeberg B et al: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation, 2005; 112: 1965-70
14. Demir M, Demir C: Effect of Hepatitis C Virus Infection on the Left Ventricular Systolic and Diastolic Functions. South Med J, 104: 543-46
15. Demir M, Demir C, Ülçay A: Effect of Hepatitis C Virus Infection on the Left Ventricular Hypertrophy. Turkiye Klinikleri J Cardiovasc Sci, 2009; 21: 315-19
16. Amirzadegan A, Davoodi, Boroumand MA et al: Association between hepatitis B surface antibody seropositivity and coronary artery disease. Indian J Med Sci, 2007; 61: 648-55
17. Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) Study Group, Weber R, Sabin C, Reiss P et al: HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals. Antivir Ther, 2010; 15: 1077-86
18. Turhan O, Coban E, Inan D, Yalcin AN: Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit, 2010; 16(4): CR202-5
19. Schiller NB, Shah PM, Crawford M et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr, 1989; 2: 358-67
20. Lang RM, Bierig M, Devereux RB et al: Recommendations for chamber quantification. Eur J Echocardiogr, 2006; 7: 79-108
21. Rudski LG, Lai WW, Afilalo J et al: Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr, 2010; 23: 685-713
22. Matsumori A: Role of hepatitis C virus in cardiomyopathies. Ernst Schering Res Found Workshop, 2006: 99-120
23. Ishizaka N, Ishizaka Y, Takahashi E et al: Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation, 2002; 105: 1028-30
24. Wang L, Geng J, Li J et al: The biomarker N-terminal pro-brain natriuretic peptide and liver diseases. Clin Invest Med, 2011; 34(1): E30-37
25. Kucukazman M, Ata N, Yavuz B et al: Elevation of B-type natriuretic Peptide level in asymptomatic hepatitis B virus-positive patients is not associated with abnormalities of cardiac function. Med Princ Pract, 2012; 21: 150-55
26. El-Waseef MM, Taha S, Elgindi H: Left ventricular diastolic abnormalities and the impact of hepatitis C virus infection in multitransfused Egyptian children. Arch Med Sci, 2010; 6(1): 96-99